| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Mineralys Therapeutics, Inc. | Director | Common Stock | 0 | $0 | $46.50 | 13 Nov 2025 | Direct |
| Mineralys Therapeutics, Inc. | Director | Stock Option | 34,000 | 13 Nov 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| MLYS | Mineralys Therapeutics, Inc. | 11 Nov 2025 | 13 | -$1,197,510 | 4 | Director | 13 Nov 2025, 19:01 |
| MLYS | Mineralys Therapeutics, Inc. | 13 Feb 2025 | 1 | $0 | 4 | Director | 24 Feb 2025, 18:59 |
| MLYS | Mineralys Therapeutics, Inc. | 13 Jun 2024 | 1 | $0 | 4 | Director | 17 Jun 2024, 16:33 |
| MLYS | Mineralys Therapeutics, Inc. | 13 Jun 2024 | 0 | $0 | 3 | Director | 17 Jun 2024, 16:31 |